Daily Health & Wellness Brief · September 28th

Storyflo Health — Daily Health Brief · Sep 28, 2026 · 4m

From storyflo. This is your daily audio brief. It's Chloe, September 28th. Ten stories — evidence-led, no fluff, small inputs compound. Let's get into it. First, from STAT. STAT+: Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’. GLP-1 drugs, originally designed to help with obesity, are shifting in how they're marketed and perceived. These medications, which have already made a significant impact on the lives of many, are now being promoted more as lifestyle enhancements rather than just medical solutions. Novo Nordisk, the leading…